Impact of pegloticase on patient outcomes in refractory gout: current perspectives
Rita N Cunha,1 Renata Aguiar,1 Filipa Farinha2 1Rheumatology Department, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal; 2Centre for Rheumatology, University College London, London, UK Abstract: Gout is currently the most frequent cause of inflammatory arthritis worldwide and is responsible for...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Open Access Rheumatology : Research and Reviews |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-pegloticase-on-patient-outcomes-in-refractory-gout-current-p-peer-reviewed-article-OARRR |